LNTH · CIK 0001521036 · operating
Lantheus Holdings, Inc. (LNTH) is a in vitro & in vivo diagnostic substances company incorporated in DE, listed on the Nasdaq. With a market capitalization of $5.2 billion, Lantheus Holdings, Inc. is a mid-cap company. The stock currently trades at $76.30, up 1.86% today, with a 52-week range of $47.25–$111.29. The company trades at a trailing P/E of 31.7x and a forward P/E of 12.1x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $3.41 | $3.46 | -21.8% | |
| 2024 | $4.36 | $4.52 | -6.2% | |
| 2023 | $4.65 | $4.79 | +1062.5% | |
| 2022 | $0.40 | $0.41 | +137.7% | |
| 2021 | $-1.06 | $-1.06 | -324.0% | |
| 2020 | $-0.25 | $-0.25 | -196.2% | |
| 2019 | $0.26 | $0.27 | -23.5% | |
| 2018 | $0.34 | $0.35 | -86.2% | |
| 2017 | $2.47 | $2.58 | +1800.0% | |
| 2016 | $0.13 | $0.13 | — | |
| 2015 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001193125-26-073498 | SEC ↗ |
| 2024-12-31 | 2025-02-26 | 0001628280-25-007970 | SEC ↗ |
| 2023-12-31 | 2024-02-22 | 0001628280-24-006158 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0001628280-23-004698 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0001628280-22-003657 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001628280-21-003336 | SEC ↗ |
| 2019-12-31 | 2020-02-25 | 0001628280-20-002197 | SEC ↗ |
| 2018-12-31 | 2019-02-20 | 0001628280-19-001574 | SEC ↗ |
| 2017-12-31 | 2018-02-26 | 0001628280-18-002261 | SEC ↗ |
| 2016-12-31 | 2017-02-23 | 0001193125-17-053986 | SEC ↗ |
| 2015-12-31 | 2016-03-02 | 0001193125-16-490104 | SEC ↗ |